Erdur Sevil Karaman, Aydin Rukiye, Ozsutcu Mustafa, Olmuscelik Oktay, Eliacik Mustafa, Demirci Goktug, Kocabora Mehmet Selim
a Medicine School, Department of Ophthalmology , Istanbul Medipol University , Istanbul , Turkey.
b Medicine School, Department of Internal Medicine , Istanbul Medipol University , Istanbul , Turkey.
Curr Eye Res. 2017 Aug;42(8):1115-1117. doi: 10.1080/02713683.2017.1280511. Epub 2017 Mar 22.
The aim of this study was to evaluate tear osmolarity and tear film function and ocular surface changes in patients with metabolic syndrome.
108 eyes of 64 patients with metabolic syndrome (group 1) and 110 eyes of 55 healthy individuals (group 2) were included in this cross-sectional study. All participants were evaluated using the Ocular Surface Disease Index (OSDI) questionnaire, Schirmer I test, tear film break-up time (TBUT), and tear osmolarity. Main outcome measures were Ocular Surface Disease Index (OSDI) questionnaire, Schirmer I test, tear film break-up time (TBUT), and tear osmolarity values.
Tear osmolarity values and OSDI scores were significantly higher in group 1 (314.4 ± 19.1 mOsm and 38.9 ± 1.1, respectively) compared with group 2 (295 ± 14.3 mOsm and 18.69 ± 17.2, respectively) (p = 0.01 for both). The Schirmer test values and TBUT in group 1 (10 ± 3.7 mm and 14.8 ± 3.6 sec, respectively) were significantly lower compared with group 2 (16.8 ± 2.6 mm and 18.1 ± 0.5 sec, respectively) (p < 0.001 for both). There was significant correlation between tear osmolarity versus waist circumference and fasting blood glucose in the study group (r = 0.364, p = 0.04; and r = 0.542, p ≤ 0.001, respectively).
This study showed that metabolic syndrome can influence tear osmolarity and tear film function. Patients with metabolic syndrome showed tear hyperosmolarity and tear film dysfunction.
本研究旨在评估代谢综合征患者的泪液渗透压、泪膜功能及眼表变化。
本横断面研究纳入了64例代谢综合征患者的108只眼(第1组)和55名健康个体的110只眼(第2组)。所有参与者均使用眼表疾病指数(OSDI)问卷、Schirmer I试验、泪膜破裂时间(TBUT)和泪液渗透压进行评估。主要观察指标为眼表疾病指数(OSDI)问卷、Schirmer I试验、泪膜破裂时间(TBUT)和泪液渗透压值。
与第2组(分别为295±14.3 mOsm和18.69±17.2)相比,第1组的泪液渗透压值和OSDI评分显著更高(分别为314.4±19.1 mOsm和38.9±1.1)(两者p值均为0.01)。与第2组(分别为16.8±2.6 mm和18.1±0.5秒)相比,第1组的Schirmer试验值和TBUT显著更低(分别为10±3.7 mm和14.8±3.6秒)(两者p值均<0.001)。研究组中泪液渗透压与腰围和空腹血糖之间存在显著相关性(r分别为0.364,p = 0.04;以及r = 0.542,p≤0.001)。
本研究表明代谢综合征可影响泪液渗透压和泪膜功能。代谢综合征患者表现出泪液高渗和泪膜功能障碍。